Autoimmune Encephalitis in Long-Standing Schizophrenia: A Case Report.

NMDA antibody NMDA encephalitis autoimmune encephalitis case report chronic schizophrenia diagnostic dilemma neuropsychiatric disorders

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2021
Historique:
received: 08 11 2021
accepted: 27 12 2021
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 1 3 2022
Statut: epublish

Résumé

Anti-N-methyl-D-aspartate (NMDA) receptor antibody (anti-NMDAR Ab)-mediated encephalitis is an autoimmune disorder involving the production of antibodies against NMDARs in the central nervous system that leads to neurological or psychiatric dysfunction. Initially described as a paraneoplastic syndrome in young women with teratomas, increased testing has found it to be a heterogeneous condition that affects both the sexes with varying clinical manifestations, severity, and aetiology. This case report describes a 67-year-old man with a 40-year history of relapsing, severe, treatment-refractory schizophrenia. Due to the worsening of his condition during a prolonged inpatient admission for presumed relapse of psychosis, a revisit of the original diagnosis was considered with extensive investigations performed including an autoimmune panel. This revealed anti-NMDAR Abs in both the serum and cerebrospinal fluid on two occasions. Following treatment with intravenous immunoglobulin and methylprednisolone, he demonstrated rapid symptom improvement. This is a rare case of a long-standing psychiatric presentation with a preexisting diagnosis of schizophrenia subsequently found to have anti-NMDAR Ab-mediated encephalitis. Whether the case is one of initial NMDAR encephalitis vs. overlap syndrome is unknown. Most importantly, this case highlights the need for vigilance and balanced consideration for treatment in cases of long-standing psychiatric presentation where the case remains treatment refractory to antipsychotics or when atypical features including seizures and autonomic dysfunction or focal neurology are observed.

Identifiants

pubmed: 35222231
doi: 10.3389/fneur.2021.810926
pmc: PMC8873086
doi:

Types de publication

Case Reports

Langues

eng

Pagination

810926

Informations de copyright

Copyright © 2022 Vaux, Robinson, Saglam, Cheuk, Kilpatrick, Evans and Monif.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mov Disord. 2008 Jul 15;23(9):1256-61
pubmed: 18442127
Mol Psychiatry. 2014 Oct;19(10):1143-9
pubmed: 23999527
Ann Neurol. 2009 Jul;66(1):11-8
pubmed: 19670433
JAMA Neurol. 2014 Mar;71(3):344-6
pubmed: 24473671
Rinsho Shinkeigaku. 2017 Jan 31;57(1):37-40
pubmed: 27980287
Mediators Inflamm. 2017;2017:6361479
pubmed: 28698711
Ann Neurol. 2012 Dec;72(6):902-11
pubmed: 23280840
Neurology. 2013 Sep 17;81(12):1058-63
pubmed: 23946310
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
Brain Stimul. 2019 Mar - Apr;12(2):329-334
pubmed: 30528383
Intern Med. 2020 Sep 15;59(18):2301-2306
pubmed: 32522922
Seizure. 2019 Feb;65:20-24
pubmed: 30597400
Neurology. 2011 Sep 6;77(10):996-9
pubmed: 21865579
Neurology. 2021 Jul 6;97(1):e61-e75
pubmed: 33980703
Indian J Nucl Med. 2011 Apr;26(2):99-101
pubmed: 22174517
Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352
pubmed: 28567435
Neuropsychiatr Dis Treat. 2019 Apr 02;15:773-778
pubmed: 31040676
Ann Neurol. 2014 Feb;75(2):317-23
pubmed: 24318406
Brain. 2010 Jun;133(Pt 6):1655-67
pubmed: 20511282
Lancet Neurol. 2011 Jan;10(1):63-74
pubmed: 21163445
Ann Neurol. 2007 Jan;61(1):25-36
pubmed: 17262855
J Clin Neurosci. 2018 Jun;52:54-59
pubmed: 29605275
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-768
pubmed: 33649022
Neurol Clin Pract. 2016 Feb;6(1):69-72
pubmed: 29443234
Transl Psychiatry. 2021 Nov 5;11(1):566
pubmed: 34741015
Ann Neurol. 2005 Oct;58(4):594-604
pubmed: 16178029
Neurology. 2018 Apr 17;90(16):e1386-e1394
pubmed: 29549218
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Clin Neurophysiol. 2019 Feb;130(2):289-296
pubmed: 30611120
Mol Psychiatry. 2016 Aug;21(8):1009-26
pubmed: 27271499
Front Psychiatry. 2021 Mar 26;12:654602
pubmed: 33841216
JAMA Psychiatry. 2013 Mar;70(3):271-8
pubmed: 23344076
Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):210-221
pubmed: 28783929
Int J STD AIDS. 2019 Feb;30(2):194-197
pubmed: 30253732
Neurology. 2012 Sep 11;79(11):1094-100
pubmed: 22933737
Clin Infect Dis. 2012 Apr;54(7):899-904
pubmed: 22281844
Neurology. 2013 Oct 29;81(18):1637-9
pubmed: 24089390
Am Fam Physician. 2016 Oct 15;94(8):635-641
pubmed: 27929229
J ECT. 2010 Jun;26(2):126-30
pubmed: 20514696
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Front Neurol. 2021 Feb 22;12:607773
pubmed: 33692738

Auteurs

Amy Vaux (A)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Karen Robinson (K)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Burcu Saglam (B)

Department of Psychiatry, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Nathan Cheuk (N)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Trevor Kilpatrick (T)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.

Andrew Evans (A)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Mastura Monif (M)

Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Department of Neuroscience, Monash University, Melbourne, VIC, Australia.

Classifications MeSH